Kejing Wang1,2, Shuang Wen1,2, Jiao Jiao1,2, Tingting Tang1,2, Xin Zhao3, Min Zhang1,2, Bingjie Lv1,2, Yuzhi Lu1,2, Xingdi Zhou1,2, Jingyong Li1,2, Shaofang Nie1,2, Yuhua Liao1,2, Qing Wang4, Xin Tu4, Ziad Mallat5, Ni Xia1,2, Xiang Cheng1,2. 1. Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 2. Key Laboratory of Biological Targeted Therapy of Education Ministry and Hubei Province, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 3. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. 4. Key Laboratory of Molecular Biophysics of the Ministry of Education, Cardio-X Institute, College of Life Science and Technology and Center of Human Genome Research, Huazhong University of Science and Technology, Wuhan, China. 5. Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.
Abstract
BACKGROUND AND PURPOSE: The immune system plays an important role in driving the acute inflammatory response following myocardial ischaemia/reperfusion injury (MIRI). IL-21 is a pleiotropic cytokine with multiple immunomodulatory effects, but its role in MIRI is not known. EXPERIMENTAL APPROACH: Myocardial injury, neutrophil infiltration and the expression of neutrophil chemokines KC (CXCL1) and MIP-2 (CXCL2) were studied in a mouse model of MIRI. Effects of IL-21 on the expression of KC and MIP-2 in neonatal mouse cardiomyocytes (CMs) and cardiac fibroblasts (CFs) were determined by real-time PCR and ELISA. The signalling mechanisms underlying these effects were explored by western blot analysis. KEY RESULTS: IL-21 was elevated within the acute phase of murine MIRI. Neutralization of IL-21 attenuated myocardial injury, as illustrated by reduced infarct size, decreased cardiac troponin T levels and improved cardiac function, whereas exogenous IL-21 administration exerted opposite effects. IL-21 increased the infiltration of neutrophils and increased the expression of KC and MIP-2 in myocardial tissue following MIRI. Moreover, neutrophil depletion attenuated the IL-21-induced myocardial injury. Mechanistically, IL-21 increased the production of KC and MIP-2 in neonatal CMs and CFs, and enhanced neutrophil migration, as revealed by the migration assay. Furthermore, we demonstrated that this IL-21-mediated increase in chemokine expression involved the activation of Akt/NF-κB signalling in CMs and p38 MAPK/NF-κB signalling in CFs. CONCLUSIONS AND IMPLICATIONS: Our data provide novel evidence that IL-21 plays a pathogenic role in MIRI, most likely by promoting cardiac neutrophil infiltration. Therefore, targeting IL-21 may have therapeutic potential as a treatment for MIRI. LINKED ARTICLES: This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.
BACKGROUND AND PURPOSE: The immune system plays an important role in driving the acute inflammatory response following myocardial ischaemia/reperfusion injury (MIRI). IL-21 is a pleiotropic cytokine with multiple immunomodulatory effects, but its role in MIRI is not known. EXPERIMENTAL APPROACH: Myocardial injury, neutrophil infiltration and the expression of neutrophil chemokines KC (CXCL1) and MIP-2 (CXCL2) were studied in a mouse model of MIRI. Effects of IL-21 on the expression of KC and MIP-2 in neonatal mouse cardiomyocytes (CMs) and cardiac fibroblasts (CFs) were determined by real-time PCR and ELISA. The signalling mechanisms underlying these effects were explored by western blot analysis. KEY RESULTS:IL-21 was elevated within the acute phase of murine MIRI. Neutralization of IL-21attenuated myocardial injury, as illustrated by reduced infarct size, decreased cardiac troponin T levels and improved cardiac function, whereas exogenous IL-21 administration exerted opposite effects. IL-21 increased the infiltration of neutrophils and increased the expression of KC and MIP-2 in myocardial tissue following MIRI. Moreover, neutrophil depletion attenuated the IL-21-induced myocardial injury. Mechanistically, IL-21 increased the production of KC and MIP-2 in neonatal CMs and CFs, and enhanced neutrophil migration, as revealed by the migration assay. Furthermore, we demonstrated that this IL-21-mediated increase in chemokine expression involved the activation of Akt/NF-κB signalling in CMs and p38 MAPK/NF-κB signalling in CFs. CONCLUSIONS AND IMPLICATIONS: Our data provide novel evidence that IL-21 plays a pathogenic role in MIRI, most likely by promoting cardiac neutrophil infiltration. Therefore, targeting IL-21 may have therapeutic potential as a treatment for MIRI. LINKED ARTICLES: This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.
Authors: Yinbo Li; Christopher D Garson; Yaqin Xu; Ronald J Beyers; Frederick H Epstein; Brent A French; John A Hossack Journal: Ultrasound Med Biol Date: 2007-04-16 Impact factor: 2.998
Authors: Jörg H W Distler; Astrid Jüngel; Otylia Kowal-Bielecka; Beat A Michel; Renate E Gay; Haiko Sprott; Marco Matucci-Cerinic; Meike Chilla; Kristian Reich; Joachim R Kalden; Ulf Müller-Ladner; Hanns M Lorenz; Steffen Gay; Oliver Distler Journal: Arthritis Rheum Date: 2005-03
Authors: Jonathan M Coquet; Konstantinos Kyparissoudis; Daniel G Pellicci; Gurdyal Besra; Stuart P Berzins; Mark J Smyth; Dale I Godfrey Journal: J Immunol Date: 2007-03-01 Impact factor: 5.422
Authors: Irene Puga; Montserrat Cols; Carolina M Barra; Bing He; Linda Cassis; Maurizio Gentile; Laura Comerma; Alejo Chorny; Meimei Shan; Weifeng Xu; Giuliana Magri; Daniel M Knowles; Wayne Tam; April Chiu; James B Bussel; Sergi Serrano; José Antonio Lorente; Beatriz Bellosillo; Josep Lloreta; Nuria Juanpere; Francesc Alameda; Teresa Baró; Cristina Díaz de Heredia; Núria Torán; Albert Català; Montserrat Torrebadell; Claudia Fortuny; Victoria Cusí; Carmen Carreras; George A Diaz; J Magarian Blander; Claire-Michèle Farber; Guido Silvestri; Charlotte Cunningham-Rundles; Michaela Calvillo; Carlo Dufour; Lucia Dora Notarangelo; Vassilios Lougaris; Alessandro Plebani; Jean-Laurent Casanova; Stephanie C Ganal; Andreas Diefenbach; Juan Ignacio Aróstegui; Manel Juan; Jordi Yagüe; Nizar Mahlaoui; Jean Donadieu; Kang Chen; Andrea Cerutti Journal: Nat Immunol Date: 2011-12-25 Impact factor: 25.606
Authors: Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2015-12 Impact factor: 8.739